Watch Ticker

Akebia Therapeutics, Inc.

Go to Akebia Therapeutics, Inc. Website

$3.72

-0.04 (-1.06%)

Live

Previous Close

$3.72

Day Range

$3.6911 - $3.775

Previous Day Range

$3.67 - $3.76

Market Cap

$987.5 million USD

Day Vol.

2.4 million

Previous Day Vol.

2.5 million

Currency

USD

Primary Exchange

Nasdaq

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company include...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Mercedes Carrasco - Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

Akebia Therapeutics' Chief Commercial Officer Nik Grund will participate in a Fireside Chat at the 4th Annual Kidney Virtual Conference on July 14, 2025, discussing the company's kidney disease research and developments.

Related tickers: AKBA.

Read Full Article

N/A - AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

Averoa, a biopharmaceutical company, has received European marketing authorization for its oral therapy XOANACYL, which addresses iron deficiency and hyperphosphatemia in chronic kidney disease patients.

Related tickers: AKBA.

Read Full Article

Trending Tickers

Please sign in to view